Works by van Raalte, Daniel H.
Results: 81
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Pancreatic <sup>18</sup>F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0213202
- By:
- Publication type:
- Article
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.
- Published in:
- Endocrine Reviews, 2021, v. 42, n. 5, p. 528, doi. 10.1210/endrev/bnab021
- By:
- Publication type:
- Article
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications.
- Published in:
- Endocrine Reviews, 2020, v. 41, n. 2, p. 202, doi. 10.1210/endrev/bnz010
- By:
- Publication type:
- Article
Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2024, v. 47, n. 7, p. 1114, doi. 10.2337/dc23-0776
- By:
- Publication type:
- Article
Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2024, v. 47, n. 3, p. 409, doi. 10.2337/dc23-1818
- By:
- Publication type:
- Article
Age Ain't Nothing But a Number... or Is It?
- Published in:
- Diabetes Care, 2023, v. 46, n. 6, p. 1135, doi. 10.2337/dci23-0013
- By:
- Publication type:
- Article
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Differences in Body Composition Convey a Similar Risk of Type 2 Diabetes Among Different Ethnic Groups With Disparate Cardiometabolic Risk-The HELIUS Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.
- Published in:
- Diabetes Care, 2020, v. 43, n. 1, p. 228, doi. 10.2337/dc19-1651
- By:
- Publication type:
- Article
Sleep and HbA<sub>1c</sub> in Patients With Type 2 Diabetes: Which Sleep Characteristics Matter Most?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2019, v. 42, n. 10, p. 1921, doi. 10.2337/dc19-0937
- By:
- Publication type:
- Article
The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comment on Lovshin et al. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α<sup>1-67</sup> in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Glucagon-Like Peptide. 1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans.
- Published in:
- Diabetes Care, 2011, v. 34, n. 2, p. 412, doi. 10.2337/dc10-1677
- By:
- Publication type:
- Article
Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01492-x
- By:
- Publication type:
- Article
Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 1, p. 81, doi. 10.1007/s00592-020-01581-x
- By:
- Publication type:
- Article
Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injury.
- Published in:
- Intensive Care Medicine Experimental, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40635-024-00647-2
- By:
- Publication type:
- Article
Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 5, p. 747, doi. 10.3390/jpm13050747
- By:
- Publication type:
- Article
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study.
- Published in:
- Cardiovascular Research, 2024, v. 120, n. 4, p. 372, doi. 10.1093/cvr/cvae018
- By:
- Publication type:
- Article
Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 5, p. 916, doi. 10.1093/cvr/cvz323
- By:
- Publication type:
- Article
Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3766, doi. 10.1111/dom.15272
- By:
- Publication type:
- Article
Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1758, doi. 10.1111/dom.15033
- By:
- Publication type:
- Article
Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 198, doi. 10.1111/dom.14864
- By:
- Publication type:
- Article
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1578, doi. 10.1111/dom.14729
- By:
- Publication type:
- Article
Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 115, doi. 10.1111/dom.14557
- By:
- Publication type:
- Article
Iloprost infusion prevents the insulin‐induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2523, doi. 10.1111/dom.13410
- By:
- Publication type:
- Article
Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: <italic>Post‐hoc</italic> analyses of four clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1235, doi. 10.1111/dom.13223
- By:
- Publication type:
- Article
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1669, doi. 10.1111/dom.12985
- By:
- Publication type:
- Article
Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1205, doi. 10.1111/dom.12935
- By:
- Publication type:
- Article
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1217, doi. 10.1111/dom.12748
- By:
- Publication type:
- Article
Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
- Published in:
- European Journal of Endocrinology, 2024, v. 190, n. 5, p. 391, doi. 10.1093/ejendo/lvae043
- By:
- Publication type:
- Article
Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
- Published in:
- European Journal of Endocrinology, 2017, v. 176, n. 1, p. 77, doi. 10.1530/EJE-16-0507
- By:
- Publication type:
- Article
Renal sinus fat and renal hemodynamics: a cross-sectional analysis.
- Published in:
- MAGMA: Magnetic Resonance Materials in Physics, Biology & Medicine, 2020, v. 33, n. 1, p. 73, doi. 10.1007/s10334-019-00773-z
- By:
- Publication type:
- Article
Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, p. i24, doi. 10.1093/ndt/gfz228
- By:
- Publication type:
- Article
Corrigendum: Safety of Semaglutide.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Safety of Semaglutide.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.645563
- By:
- Publication type:
- Article
Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity.
- Published in:
- BMC Medical Genomics, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s12920-015-0096-y
- By:
- Publication type:
- Article